for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for U.S.

Dec 22 (Reuters) - Drug developer Ocugen Inc will co-develop India-based Bharat Biotech’s COVID-19 vaccine candidate for the U.S. market, the companies said on Tuesday.

The vaccine candidate, Covaxin, is currently in a late-stage study in India. (Reporting by Trisha Roy in Bengaluru; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up